[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 15, Issue 6 (3-2014) ::
2014, 15(6): 514-518 Back to browse issues page
Effect of Chromium Supplementation on Lipid Profile in Patients with Type 2 Diabetes Mellitus
Saeid Kalbasi , Azam Erfanifar , Hale Afshar , Latif Gachkar , Batool Ghorbani Yekta , Katayon Enteshari
Shahid beheshti university of medical science, Tehran, Iran , erfanifarazam@sbmu.ac.ir
Abstract:   (8665 Views)

Introduction: Although current data shows that chromium supplementation in type 2 Diabetic patients can improve control blood sugar and lipids there are controversial results about its relevance to improving blood sugar and  lipids in diabetes. This study investigates the effect of chromium picolinate supplement on blood sugar and lipids control in patients with type 2 diabetes. Materials and Methods: This randomized, double-blind,placebo-controlled study was carried out at the Diabetes Clinic of the Loghman Hospital in collaboration with Taban Diabetes Clinic. In this clinical study of 60 patients with type 2 Diabetes, participants were randomized into the double-blind treatment and control groups for 3 months of treatment with 200 µg of chromium picolinate or placebo respectively. Blood sugar and lipids profile were assessed at the beginning and end of the study. Results: Based on the result of this study it has been found that 200 micrograms of chromium consumed over three months could decrease of TG levels dramatically, compared to placebos. TG changes were significantly different between the two groups, (P=0.048), without any change in other lipid profiles of the two groups. Findings showed that chromium picolinate treatment for 90 days produced significant improvements in glycemic control compared to placebo, based on significant reductions in both FPG and HbA1c levels in patients with type 2 diabetes mellitus, with significant changes between the two groups (P<0.001). Conclusions: Results of this study recommend that chromium picolinate prescribed to type 2 diabetes patients could decrease TG, HbA1c and FPG levels.

Keywords: Chromium picolinate, Type 2 Diabetes, Blood sugar and lipids
Full-Text [PDF 262 kb]   (3483 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2013/04/9 | Accepted: 2013/08/13 | Published: 2014/03/18
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kalbasi S, Erfanifar A, Afshar H, Gachkar L, Ghorbani Yekta B, Enteshari K. Effect of Chromium Supplementation on Lipid Profile in Patients with Type 2 Diabetes Mellitus. Iranian Journal of Endocrinology and Metabolism 2014; 15 (6) :514-518
URL: http://ijem.sbmu.ac.ir/article-1-1530-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 6 (3-2014) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4624